Myelodysplastic syndromes: disease overview and therapy options.
The increase in new cases of myelodysplastic syndromes is likely attributable to both an aging population and a greater number of cancer survivors who have received chemotherapy. A detailed diagnostic history is critical in order to place a patient in the proper treatment category.